Robert S. Mancini received his Doctorate of Pharmacy from the University of California, San Diego. He went on to complete a PGY1 residency at St. Luke’s Health System and PGY2 at St. Luke’s Cancer Institute.

Dr. Mancini currently serves as the BMT Pharmacy Program Coordinator at St. Luke’s Cancer Institute in Boise, ID and serves as clinical oncology faculty at Idaho State University College of Pharmacy, where he coordinates the oncology module and has started a Special Topics in Oncology elective course. Dr. Mancini also serves as the Director of the Oncology Pharmacy Residency Program at St. Luke’s.

Previously, he has served as national president of Kappa Psi Pharmaceutical Fraternity, Inc and on numerous HOPA committees and task forces, including Education, Publications, BCOP Self-Study, HOPA Journal, Oral Chemo Standards, Value of Heme/Onc Pharmacists, Practice Outcomes, and as chair of Needs Assessment.

Dr. Mancini was instrumental in the establishment and development of St. Luke’s Oral Chemotherapy Program, Supportive Care Clinics, and Allogeneic Blood and Marrow Transplant Program with numerous publications and presentations.